There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Avita Medical (RCEL – Research Report) and Ehealth (EHTH – Research Report) with bullish sentiments.
Avita Medical (RCEL)
Lake Street analyst Brooks O’Neil reiterated a Buy rating on Avita Medical today and set a price target of $40.00. The company’s shares closed last Monday at $10.80.
According to TipRanks.com, O’Neil is a 1-star analyst with an average return of
Currently, the analyst consensus on Avita Medical is a Strong Buy with an average price target of $28.40, a 100.6% upside from current levels. In a report released yesterday, Cantor Fitzgerald also assigned a Buy rating to the stock with a $26.00 price target.
See today’s best-performing stocks on TipRanks >>
Ehealth (EHTH)
Craig-Hallum analyst Alexander Nowak maintained a Buy rating on Ehealth today. The company’s shares closed last Monday at $7.77.
According to TipRanks.com, Nowak has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Ehealth with a $11.50 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on RCEL:
- AVITA Medical Receives Best Product Award at the American Association for the Surgery of Trauma
- AVITA Medical to Present at the Cantor Global Healthcare Conference
- AVITA Medical to Participate in Upcoming Investor Conferences
- AVITA Medical to Host Investor Webinar Briefing
- Avita Medical price target raised to $23 from $18.50 at Piper Sandler
